The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey

David Dingli, Joana E. Matos, Kerri Lehrhaupt, Sangeeta Krishnan, Michael Yeh, Jesse Fishman, Sujata P. Sarda, Scott B. Baver

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey'. Together they form a unique fingerprint.

Medicine & Life Sciences